BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8670586)

  • 1. Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia.
    Narváez J; Rodriguez-Moreno J; Moragues C; Campoy E; Clavaguera T; Roig-Escofet D
    Br J Rheumatol; 1996 Jun; 35(6):598-600. PubMed ID: 8670586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
    Moreira RO; Leal CT; Lacativa PG; Figueiredo JG; Lima MB; Farias ML
    Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):150-5. PubMed ID: 16628288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
    Firth RG; Grant CS; Riggs BL
    Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
    Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL; Feig DS; Blackstein ME
    J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial adult onset X-linked hypophosphataemic osteomalacia (report of a family; clinical and experimental studies).
    Radó JP; Haris A; Szebenyi B
    Acta Physiol Hung; 1997-1998; 85(3):199-214. PubMed ID: 10101535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
    Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique case of adult hypophosphatemic osteomalacia.
    Edelson GW; Shih MS; Parfitt AM
    Bone; 1993; 14(5):707-10. PubMed ID: 8268043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tertiary hyperparathyroidism induced by the treatment of hypophosphatemic osteomalacia].
    Vedere V; Goupille P; Valat JP; Lecomte P
    Ann Endocrinol (Paris); 1996; 57(3):215-8. PubMed ID: 8949417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-familial vitamin D-resistant hypophosphataemic osteomalacia of adult onset: case report.
    Reeve JK; Palmer DG
    N Z Med J; 1976 Jan; 83(555):15-7. PubMed ID: 1062192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adult-onset sex-linked familial hypophosphatemic osteomalacia].
    Radó J; Haris A; Szebenyi B
    Orv Hetil; 1997 Jun; 138(26):1683-8. PubMed ID: 9289682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic hypophosphataemic osteomalacia with onset in adolescence. Observations on its course over a period of 17 years].
    Fanconi A
    Helv Paediatr Acta; 1971 Dec; 26(5):535-49. PubMed ID: 5142937
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypophosphataemic osteomalacia due to de Toni-Debre-Fanconi syndrome in a 19-year old girl.
    Tsilchorozidou T; Yovos JG
    Hormones (Athens); 2005; 4(3):171-6. PubMed ID: 16613828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypophosphataemic vitamin D-resistant rickets and adult presenting hypophosphataemic vitamin D-resistant osteomalacia.
    Eguchi M; Kaibara N
    Int Orthop; 1980; 3(4):257-64. PubMed ID: 7399764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphatemic osteomalacia as a long-term complication after liver transplantation.
    Kawate H; Taketomi A; Watanabe T; Nomura M; Kato M; Sakamoto R; Ikegami T; Soejima Y; Maehara Y; Takayanagi R
    Transplantation; 2011 Jan; 91(1):e6-8. PubMed ID: 21441849
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypophosphatemic oncogenic osteomalacia].
    Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
    Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy.
    McHenry CR; Mostafavi K; Murphy TA
    Endocr Pract; 2006; 12(3):294-8. PubMed ID: 16772203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.